Comparison of efficacy and safety of cyclosporine (CsA) discontinuation with introduction of sirolimus (SRL) at week 12 to standard strategy in renal transplant recipients receiving mycophenolate mofetil (MMF).

被引:0
|
作者
Lebranchu, Y. [1 ]
Etienne, I. [1 ]
Touchard, G. [1 ]
Thervet, E. [1 ]
Westeel, P. F. [1 ]
Toupance, O. [1 ]
de Ligny, B. Hurault [1 ]
Moulin, B. [1 ]
Frouget, T. [1 ]
Le Meur, Y. [1 ]
Glotz, D. [1 ]
Mignon, F. [1 ]
Deteix, P. [1 ]
Subra, J. F. [1 ]
Bayle, F. [1 ]
Noel, C. [1 ]
Hayem, C. [1 ]
Girardot-Seguin, S. [1 ]
Buehler, M. [1 ]
机构
[1] CHU Bretonneau, Tours, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
53
引用
收藏
页码:160 / 160
页数:1
相关论文
共 36 条
  • [1] Comparison at one year of interstitial fibrosis (IF) by automatic quantification in renal transplant recipients with cyclosporine (CsA) discontinuation and sirolimus (SRL) introduction
    Servais, Aude
    Meas-Yedid, Vannary
    Lebranchu, Yvon
    Etienne, Isabelle
    Touchard, Guy
    Legendre, Christophe
    Westeel, Pierre Francois
    Toupance, Olivier
    de Ligny, Bruno Hurault
    Olivo-Marin, Christophe
    Thervet, Eric
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 319 - 319
  • [2] Conversion of cyclosporine (neoral;: CsA) to mycophenolate mofetil (MMF) in stable renal transplant recipients.
    Schrama, YC
    Hené, RJ
    Boer, P
    Koomans, HA
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (04) : 1625 - 1626
  • [3] EFFICACY AND SAFETY OF EARLY CYCLOSPORINE (CsA) CONVERSION TO SIROLIMUS (SRL) WITH MYCOPHENOLATE MOFETIL (MMF): 5-YEAR RESULTS OF THE POST-CONCEPT STUDY
    Lebranchu, Y.
    Touchard, G.
    Buechler, M.
    Thervet, E.
    Etienne, I.
    Westeel, P-F
    de Ligny, B. Hurault
    Moulin, B.
    Rerolle, J. -P.
    Seguin, S. Girardot
    Toupance, O.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 57 - 57
  • [4] Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients
    Miller, J
    Mendez, R
    Pirsch, JD
    Jensik, SC
    [J]. TRANSPLANTATION, 2000, 69 (05) : 875 - 880
  • [5] IMPACT OF INTERSTITIAL FIBROSIS (IF) BY AUTOMATIC QUANTIFICATION AT ONE YEAR ON THE EVOLUTION OF RENAL FUNCTION IN TRANSPLANT RECIPIENTS WITH CYCLOSPORINE (CSA) DISCONTINUATION AND SIROLIMUS (SRL) INTRODUCTION
    Servais, Aude
    Meas-Yedid, Vannary
    Toupance, Olivier
    Lebranchu, Yvon
    Touchard, Guy
    Westeel, Pierre Francois
    Etienne, Isabelle
    Moulin, Bruno
    de Ligny, Bruno Hurault
    Le Pogamp, Patrick
    Hayem, Cecile
    Marin, Jean Christophe Olivo
    Thervet, Eric
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 174 - 174
  • [6] Pharmacokinetics, safety and efficacy of mycophenolate mofetil in combination with sirolimus vs cyclosporine in renal transplant patients.
    Pescovitz, M
    Vincenti, F
    Hart, M
    Melton, L
    Whelchel, J
    Mulgaonkar, S
    McKay, D
    Leung, M
    Calleja, E
    Ghahramani, P
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 251 - 251
  • [7] Efficacy and Safety of Basiliximab in Pediatric Renal Transplant Patients Receiving Cyclosporine, Mycophenolate Mofetil, and Steroids
    Offner, Gisela
    Toenshoff, Burkhard
    Hoecker, Britta
    Krauss, Manuela
    Bulla, Monika
    Cochat, Pierre
    Fehrenbach, Henry
    Fischer, Wolfgang
    Foulard, Michel
    Hoppe, Bernd
    Hoyer, Peter F.
    Jungraithmayr, Therese C.
    Klaus, Guenter
    Latta, Kay
    Leichter, Heinz
    Mihatsch, Michael J.
    Misselwitz, Joachim
    Montoya, Carmen
    Mueller-Wiefel, Dirk E.
    Neuhaus, Thomas J.
    Pape, Lars
    Querfeld, Uwe
    Plank, Christian
    Schwarke, Dieter
    Wygoda, Simone
    Zimmerhackl, Lothar B.
    [J]. TRANSPLANTATION, 2008, 86 (09) : 1241 - 1248
  • [8] Spare-the-nephron (STN) trial in liver transplant recipients: Interim efficacy and safety of mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy after CNI withdrawal
    Sher, L.
    Marotta, P.
    Teperman, L.
    Sebastian, A.
    Moonka, D.
    Koneru, B.
    Patel, D.
    Klintmalm, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 179 - 179
  • [9] TOLERABILITY AND RENAL SPARING OF MYCOPHENOLATE MOFETIL MMF/SIROLIMUS (SRL) MAINTENANCE THERAPY IN LIVER TRANSPLANT RECIPIENTS: 12-MONTH RESULTS OF THE SPARE-THE-NEPHRON (STN) TRIAL
    Teperman, L.
    Marotta, P.
    Sher, L.
    Sebastian, A.
    Moonka, D.
    Patel, D.
    Koneru, B.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S224 - S224
  • [10] Efficacy and safety of mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy after calcineurin inhibitor (CNI) withdrawal in renal transplant recipients: Final results of the spare-the-nephron (STN) trial.
    Pearson, T. C.
    Mulgaonkar, S.
    Patel, A.
    Scandling, J.
    Shidban, H.
    Weir, M.
    Patel, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 213 - 213